Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 DiabetesAiwen Li, Christopher Fotsch, Maurice G. Emery et al.|ACS Medicinal Chemistry Letters|2011Cited by 21
Activity-based exposure comparisons among humans and nonclinical safety testing species in an extensively metabolized drug candidateXiaochun Zhu, Raju Subramanian, J. Greg Slatter et al.|Xenobiotica|2012Cited by 5